Article PDF
Rights and permissions
About this article
Cite this article
Fibroblast growth factor receptor 1 ( FGFR1 ; CD331 ), FGFR2 and fibroblast growth factor 19 ( FGF19 ) amplification may help predict sensitivity to FGFR inhibitors in cancer. Science-Business eXchange 5, 1067 (2012). https://doi.org/10.1038/scibx.2012.1067
Issue Date:
DOI: https://doi.org/10.1038/scibx.2012.1067